9837 related articles for article (PubMed ID: 18695716)
1. [Myelopeptide MP-5 and fluorescent derivatives: synthesis and biological activity].
Fonina LA; Az'muko AA; Kalikhevich VN; Levit ML; Ardemasova ZA; Gur'ianov SA; Belevskaia RG; Efremov MA; Treshchalina EM; Mikhaĭlova AA
Bioorg Khim; 2008; 34(4):451-6. PubMed ID: 18695716
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and properties of the retro-analogue of myelopeptide MP-2].
Fonina LA; Ovchinnikov MV; Gur'ianov SA; Sychev SV; Belevskaia RG; Treshchalina EM
Bioorg Khim; 2005; 31(3):239-44. PubMed ID: 16004381
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and anti-tumor properties of myelopeptide MP-1].
Fonina LA; Treshchalina EM; Belevskaia RG; Az'muko AA; Efremov MA; Sedakova LA; Kirilina EA
Bioorg Khim; 2012; 38(4):406-12. PubMed ID: 23189554
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow peptide (myelopeptide-2) abolishes induced by human leukemia HL-60 cell suppression of T lymphocytes.
Strelkov LA; Mikhailova AA; Sapozhnikov AM; Fonina LA; Petrov RV
Immunol Lett; 1996 May; 50(3):143-7. PubMed ID: 8803611
[TBL] [Abstract][Full Text] [Related]
5. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
Petrov RV; Mikhaĭlova AA; Fonina LA
Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
[TBL] [Abstract][Full Text] [Related]
6. Myelopeptide-5 abolishes virus-induced immunosuppression by restoring T cell functions.
Belyovskaya RG; Kalyuzhnaya MV; Shevchenko VP; Kirilina EA
Bull Exp Biol Med; 2009 Jan; 147(1):59-62. PubMed ID: 19526132
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and properties of the myelopeptides with differentiating activity].
Fonina LA; Kudriavtseva EV; Bespalova ZhD; Efremov MA; Mikhaĭlova AA; Kirilina EA
Bioorg Khim; 2010; 36(4):493-7. PubMed ID: 20823917
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the SH-group of myelopeptide MP-3 on its macrophage-stimulating activity].
Fonina LA; Baldin MI; Efremov MA; Gur'ianov SA; Belevskaia RG
Bioorg Khim; 2001; 27(6):403-7. PubMed ID: 11811060
[TBL] [Abstract][Full Text] [Related]
9. Bursal Hexapeptide, A Potential Immunomodulator, Inhibits Tumor Cells Proliferation via p53 Signaling Pathway.
Zhang C; Zhou J; Li S; Cai K; Guo X; Liao C; Wang C
Anticancer Agents Med Chem; 2018; 18(11):1582-1588. PubMed ID: 29866022
[TBL] [Abstract][Full Text] [Related]
10. [Fluorescently labeled differentiating myelopeptide-4: specific binding to and penetration into target cells].
Gur'ianov SA; Kirilina EA; Khaĭdukov SV; Suvorov NI; Molotkovskaia IM; Mikhaĭlova AA
Bioorg Khim; 2006; 32(6):574-8. PubMed ID: 17180907
[TBL] [Abstract][Full Text] [Related]
11. [A novel immunoregulating hexapeptide with antineoplastic effect].
Treshchalina EM; Sedakova LA; Vlasenkova NK; Zhukova OS; Firsova GA; Mikhaĭlova LM; Kolesnikova EIu; Zimakova NI; Khabarov SV; Gerasimova GK
Vopr Onkol; 2001; 47(3):321-7. PubMed ID: 11544832
[TBL] [Abstract][Full Text] [Related]
12. Myelopeptides: bone marrow regulatory mediators.
Petrov RV; Mikhailova AA; Fonina LA
Biosci Rep; 1995 Feb; 15(1):1-14. PubMed ID: 7647288
[TBL] [Abstract][Full Text] [Related]
13. Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus.
Mikhailova AA; Belevskaya RG; Kalyuzhnaya M; Fonina LA; Liashenko VA; Petrov RV
J Immunother; 2006; 29(3):306-12. PubMed ID: 16699373
[TBL] [Abstract][Full Text] [Related]
14. Myelopeptide-1 blocks the T-suppressor activity.
Petrov RV; Mikhailova AA; Kirilina EA
Folia Biol (Praha); 1994; 40(6):455-61. PubMed ID: 7589703
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel peptides through Ugi-ligation and their anti-cancer activities.
Tahoori F; Sheikhnejad R; Balalaie S; Sadjadi M
Amino Acids; 2013 Oct; 45(4):975-81. PubMed ID: 23864432
[TBL] [Abstract][Full Text] [Related]
16. Myelopeptide 6, a novel endogenous bone marrow-derived differentiation factor.
Kirilina EA; Mikhailova AA; Efremov MA; Petrov RV
Dokl Biol Sci; 2008; 421():282-5. PubMed ID: 18841816
[No Abstract] [Full Text] [Related]
17. [A myelopeptide (bivalfor), possessing antitumor activity].
Strelkov LA; Mikhaĭlova AA; Fonina LA; Gur'ianov SA; Petrov RV
Biull Eksp Biol Med; 1995 May; 119(5):530-2. PubMed ID: 7579253
[No Abstract] [Full Text] [Related]
18. Immunoregulatory effects of two bone-marrow hexapeptides (myelopeptides) in experimental models of immunodeficiency.
Mikhailova AA; Shanurin SY; Petrov RV
Immunol Lett; 1995 Sep; 47(3):199-203. PubMed ID: 8747719
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory properties of hexapeptide isolated from porcine bone marrow cell culture.
Mikhailova A; Fonina L; Kirilina E; Shanurin S; Gur'yanov S; Malakhov A; Nesmeyanov V; Petrov R
Regul Pept; 1994 Oct; 53(3):203-9. PubMed ID: 7846296
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: modification of the A segment.
Yamashita A; Norton EB; Kaplan JA; Niu C; Loganzo F; Hernandez R; Beyer CF; Annable T; Musto S; Discafani C; Zask A; Ayral-Kaloustian S
Bioorg Med Chem Lett; 2004 Nov; 14(21):5317-22. PubMed ID: 15454219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
